{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:44:15Z","timestamp":1780407855772,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"crossref","award":["2025JC-YBMS-966"],"award-info":[{"award-number":["2025JC-YBMS-966"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10108-y","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:28:43Z","timestamp":1776756523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPC25 promotes gastric cancer cells G1\/S cell cycle transition and tumorigenesis by enhancing SLC1A5-mediated glutamine metabolism"],"prefix":"10.1007","volume":"58","author":[{"given":"Xinqi","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"10108_CR1","doi-asserted-by":"publisher","unstructured":"Mazurek M, Szewc M, Sitarz MZ, Dudzi\u0144ska E, Sitarz R (2024) Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer. Cancers (Basel) 16(18). https:\/\/doi.org\/10.3390\/cancers16183163","DOI":"10.3390\/cancers16183163"},{"issue":"3","key":"10108_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"10108_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3389\/fonc.2019.01353","volume":"9","author":"Z Luo","year":"2019","unstructured":"Luo Z, Rong Z, Huang C (2019) Surgery Strategies for Gastric Cancer With Liver Metastasis. Front Oncol 9:1353. https:\/\/doi.org\/10.3389\/fonc.2019.01353","journal-title":"Front Oncol"},{"key":"10108_CR4","doi-asserted-by":"publisher","first-page":"1566939","DOI":"10.3389\/fimmu.2025.1566939","volume":"16","author":"W Pu","year":"2025","unstructured":"Pu W, Li S, Zhang J, Huang J, Li J, Jiang Y et al (2025) The efficacy and safety of PD-1\/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials. Front Immunol 16:1566939. https:\/\/doi.org\/10.3389\/fimmu.2025.1566939","journal-title":"Front Immunol"},{"issue":"5","key":"10108_CR5","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1002\/mco2.545","volume":"5","author":"Y Ding","year":"2024","unstructured":"Ding Y, Yuan Y, Weng S (2024) KEYNOTE-811: Potential to revise first-line therapy for metastatic human epidermal growth factor receptor 2-positive gastric cancer. MedComm (2020) 5(5):e545. https:\/\/doi.org\/10.1002\/mco2.545","journal-title":"MedComm (2020)"},{"key":"10108_CR6","doi-asserted-by":"publisher","first-page":"102136","DOI":"10.1016\/j.tranon.2024.102136","volume":"50","author":"X Lu","year":"2024","unstructured":"Lu X, Zhang W, Yang X, Yan X, Hussain Z, Wu Q et al (2024) Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC. Transl Oncol 50:102136. https:\/\/doi.org\/10.1016\/j.tranon.2024.102136","journal-title":"Transl Oncol"},{"key":"10108_CR7","doi-asserted-by":"publisher","first-page":"115464","DOI":"10.1016\/j.bcp.2023.115464","volume":"210","author":"S Li","year":"2023","unstructured":"Li S, Zeng H, Fan J, Wang F, Xu C, Li Y et al (2023) Glutamine metabolism in breast cancer and possible therapeutic targets. Biochem Pharmacol 210:115464. https:\/\/doi.org\/10.1016\/j.bcp.2023.115464","journal-title":"Biochem Pharmacol"},{"issue":"32","key":"10108_CR8","doi-asserted-by":"publisher","first-page":"7062","DOI":"10.2174\/0109298673297812240811182813","volume":"32","author":"S Gong","year":"2025","unstructured":"Gong S, Yang S, Zhang T, Li J, Wan X, Fang Y et al (2025) Prediction of Prognosis and Immunotherapy Response of Gastric Cancer Based on Glutamine Metabolism-related Genes. Curr Med Chem 32(32):7062\u20137081. https:\/\/doi.org\/10.2174\/0109298673297812240811182813","journal-title":"Curr Med Chem"},{"issue":"17","key":"10108_CR9","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1080\/15384101.2023.2260166","volume":"22","author":"P Malakar","year":"2023","unstructured":"Malakar P, Singha D, Choudhury D, Shukla S (2023) Glutamine regulates the cellular proliferation and cell cycle progression by modulating the mTOR mediated protein levels of \u03b2-TrCP. Cell Cycle 22(17):1937\u20131950. https:\/\/doi.org\/10.1080\/15384101.2023.2260166","journal-title":"Cell Cycle"},{"issue":"1","key":"10108_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s13402-023-00854-1","volume":"47","author":"M Chen","year":"2024","unstructured":"Chen M, Wang G, Xu Z, Sun J, Liu B, Chang L et al (2024) Loss of RACK1 promotes glutamine addiction via activating AKT\/mTOR\/ASCT2 axis to facilitate tumor growth in gastric cancer. Cell Oncol (Dordr) 47(1):113\u2013128. https:\/\/doi.org\/10.1007\/s13402-023-00854-1","journal-title":"Cell Oncol (Dordr)"},{"issue":"3\u20134","key":"10108_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10555-013-9436-6","volume":"32","author":"TA Potapova","year":"2013","unstructured":"Potapova TA, Zhu J, Li R (2013) Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev 32(3\u20134):377\u2013389. https:\/\/doi.org\/10.1007\/s10555-013-9436-6","journal-title":"Cancer Metastasis Rev"},{"issue":"22","key":"10108_CR12","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.4161\/cc.9.22.13815","volume":"9","author":"SC Sun","year":"2010","unstructured":"Sun SC, Lee SE, Xu YN, Kim NH (2010) Perturbation of Spc25 expression affects meiotic spindle organization, chromosome alignment and spindle assembly checkpoint in mouse oocytes. Cell Cycle 9(22):4552\u20134559. https:\/\/doi.org\/10.4161\/cc.9.22.13815","journal-title":"Cell Cycle"},{"key":"10108_CR13","doi-asserted-by":"publisher","unstructured":"Shi WK, Shang QL, Zhao YF (2022) SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK\/PI3K\/AKT signaling pathway through ITGB4. Oncol Rep 47(5). https:\/\/doi.org\/10.3892\/or.2022.8302","DOI":"10.3892\/or.2022.8302"},{"key":"10108_CR14","unstructured":"Yun Z, Jing W, Li H (2023) Spindle pole body component 25 regulates ovarian epithelial cancer cell proliferation and apoptosis by phosphatidylinositide 3-kinase\/protein kinase B signaling. Chin J Clin Pharmacol"},{"issue":"14","key":"10108_CR15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41388-022-02177-1","volume":"41","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Zhang X, Jiang CQ, Zhang YG, Wu X, Li J et al (2022) Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening. Oncogene 41(14):2069\u20132078. https:\/\/doi.org\/10.1038\/s41388-022-02177-1","journal-title":"Oncogene"},{"key":"10108_CR16","doi-asserted-by":"publisher","first-page":"707295","DOI":"10.3389\/fmolb.2021.707295","volume":"8","author":"Z Wu","year":"2021","unstructured":"Wu Z, Wang M, Li F, Wang F, Jia J, Feng Z et al (2021) CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer. Front Mol Biosci 8:707295. https:\/\/doi.org\/10.3389\/fmolb.2021.707295","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10108_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-025-03430-7","volume":"44","author":"W Zou","year":"2025","unstructured":"Zou W, Han Z, Wang Z, Liu Q (2025) Targeting glutamine metabolism as a potential target for cancer treatment. J Exp Clin Cancer Res 44(1):180. https:\/\/doi.org\/10.1186\/s13046-025-03430-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10108_CR18","doi-asserted-by":"publisher","first-page":"107299","DOI":"10.1016\/j.jbc.2024.107299","volume":"300","author":"J Shi","year":"2024","unstructured":"Shi J, Pabon K, Ding R, Scotto KW (2024) ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stress. J Biol Chem 300(6):107299. https:\/\/doi.org\/10.1016\/j.jbc.2024.107299","journal-title":"J Biol Chem"},{"key":"10108_CR19","doi-asserted-by":"publisher","unstructured":"Jin Y, Chen M, Chen F, Gao Z, Li X, Hu L et al (2025) The multifaceted functions of SPC25 in cancer: from molecular pathways to targeted therapy. Front Med 12. https:\/\/doi.org\/10.3389\/fmed.2025.1550901","DOI":"10.3389\/fmed.2025.1550901"},{"issue":"15","key":"10108_CR20","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.18632\/aging.102153","volume":"11","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhu Y, Li Z, Bu Q, Sun T, Wang H et al (2019) Up-regulation of SPC25 promotes breast cancer. Aging 11(15):5689\u20135704. https:\/\/doi.org\/10.18632\/aging.102153","journal-title":"Aging"},{"issue":"9","key":"10108_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/cbin.12197","volume":"48","author":"W Zhang","year":"2024","unstructured":"Zhang W, Yu L, Xu C, Tang T, Cao J, Chen L et al (2024) PLEK2 activates the PI3K\/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25. Cell Biol Int 48(9):1285\u20131300. https:\/\/doi.org\/10.1002\/cbin.12197","journal-title":"Cell Biol Int"},{"issue":"6","key":"10108_CR22","doi-asserted-by":"publisher","first-page":"155798832412978","DOI":"10.1177\/15579883241297880","volume":"18","author":"M Su","year":"2024","unstructured":"Su M, Luo J, Chen W, Li X, Ye D, Zeng X et al (2024) SPC25 Activates the Warburg Effect to Inhibit Ferroptosis in Prostate Cancer Cells. Am J Mens Health 18(6):15579883241297880. https:\/\/doi.org\/10.1177\/15579883241297880","journal-title":"Am J Mens Health"},{"issue":"5","key":"10108_CR23","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/cas.70001","volume":"116","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang H, Xu Y, Ling J, Zong C, Zhang Y et al (2025) Mefloquine Suppresses Metastasis in Renal Cell Carcinoma Through Targeting SPC25. Cancer Sci 116(5):1239\u20131254. https:\/\/doi.org\/10.1111\/cas.70001","journal-title":"Cancer Sci"},{"issue":"2","key":"10108_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.31083\/j.fbl2902069","volume":"29","author":"LX Liao","year":"2024","unstructured":"Liao LX, Zhang M, Xu X, Zhang S, Guo YZ (2024) SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression. Front Biosci (Landmark Ed) 29(2):69. https:\/\/doi.org\/10.31083\/j.fbl2902069","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4","key":"10108_CR25","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.3892\/ol.2018.8003","volume":"15","author":"F Cui","year":"2018","unstructured":"Cui F, Hu J, Fan Y, Tan J, Tang H (2018) Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer. Oncol Lett 15(4):5712\u20135720. https:\/\/doi.org\/10.3892\/ol.2018.8003","journal-title":"Oncol Lett"},{"issue":"11","key":"10108_CR26","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.18632\/aging.101631","volume":"10","author":"F Cui","year":"2018","unstructured":"Cui F, Tang H, Tan J, Hu J (2018) Spindle pole body component 25 regulates stemness of prostate cancer cells. Aging 10(11):3273\u20133282. https:\/\/doi.org\/10.18632\/aging.101631","journal-title":"Aging"},{"issue":"Suppl1","key":"10108_CR27","doi-asserted-by":"publisher","first-page":"A278","DOI":"10.1161\/res.127.suppl_1.278","volume":"127","author":"R Abouleisa","year":"2020","unstructured":"Abouleisa R, McNally L, Ou Q, Choudhary K, Thomas R, Hill BG et al (2020) Abstract 278: Metabolic Reprogramming is Essential for Cell Cycle Progression in Cardiomyocytes. Circul Res 127(Suppl1):A278\u2013A278. https:\/\/doi.org\/10.1161\/res.127.suppl_1.278","journal-title":"Circul Res"},{"key":"10108_CR28","doi-asserted-by":"publisher","unstructured":"Huang B, Chen K, Huang M, Yin Z, He W, Peng X et al (2025) TFDP1 activates SPC25-mediated glutamine metabolism to repress anti-tumor immunity of NK cells in lung adenocarcinoma. Expert Rev Clin Immunol 1\u201311. https:\/\/doi.org\/10.1080\/1744666x.2025.2524469","DOI":"10.1080\/1744666x.2025.2524469"},{"issue":"4","key":"10108_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/imm.13894","volume":"174","author":"M Luo","year":"2025","unstructured":"Luo M, Xie L, Lin B, Su X, Liang R, Ma Z et al (2025) Mechanism Study of E2F8 Activation of SPC25-Mediated Glutamine Metabolism Promoting Immune Escape in Lung Adenocarcinoma. Immunology 174(4):450\u2013461. https:\/\/doi.org\/10.1111\/imm.13894","journal-title":"Immunology"},{"issue":"8","key":"10108_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41419-023-06049-8","volume":"14","author":"L Fang","year":"2023","unstructured":"Fang L, Huang H, Lv J, Chen Z, Lu C, Jiang T et al (2023) m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming. Cell Death Dis 14(8):520. https:\/\/doi.org\/10.1038\/s41419-023-06049-8","journal-title":"Cell Death Dis"},{"issue":"1","key":"10108_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13046-018-0993-y","volume":"37","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li Z, Xuan Z, Xu P, Wang W, Chen Z et al (2018) Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis. J Exp Clin Cancer Res 37(1):320. https:\/\/doi.org\/10.1186\/s13046-018-0993-y","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10108_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/antiox12030683","volume":"12","author":"M Spada","year":"2023","unstructured":"Spada M, Piras C, Diana G, Leoni VP, Frau DV, Serreli G et al (2023) Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells. Antioxidants 12(3):683. https:\/\/doi.org\/10.3390\/antiox12030683","journal-title":"Antioxidants"},{"issue":"3","key":"10108_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/path.4518","volume":"236","author":"Q Wang","year":"2015","unstructured":"Wang Q, Hardie RA, Hoy AJ, van Geldermalsen M, Gao D, Fazli L et al (2015) Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development. J Pathol 236(3):278\u2013289. https:\/\/doi.org\/10.1002\/path.4518","journal-title":"J Pathol"},{"key":"10108_CR34","doi-asserted-by":"publisher","unstructured":"Ni J, Dai W, Liu C, Ling Y, Mou H (2023) A pan-cancer analysis of SLC1A5 in human cancers. Heliyon 9(6). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17598","DOI":"10.1016\/j.heliyon.2023.e17598"},{"key":"10108_CR35","doi-asserted-by":"publisher","unstructured":"Zhao M, Zhang D, Jiang H, Kuganesan N, Natarajan S, Pu L et al (2025) The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5. Sci Adv 11(25). https:\/\/doi.org\/10.1126\/sciadv.adv2417","DOI":"10.1126\/sciadv.adv2417"},{"issue":"3","key":"10108_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.14670\/hh-18-401","volume":"37","author":"F Li","year":"2022","unstructured":"Li F, Zhang L, Sun Q (2022) CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p. Histol Histopathol 37(3):227\u2013241. https:\/\/doi.org\/10.14670\/hh-18-401","journal-title":"Histol Histopathol"},{"key":"10108_CR37","doi-asserted-by":"publisher","unstructured":"Wang S, Lv W, Li T, Zhang S, Wang H, Li X et al (2022) Dynamic regulation and functions of mRNA m6A modification. Cancer Cell Int 22(1). https:\/\/doi.org\/10.1186\/s12935-022-02452-x","DOI":"10.1186\/s12935-022-02452-x"},{"issue":"7","key":"10108_CR38","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.Can-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T (2019) The Critical Role of RNA m(6)A Methylation in Cancer. Cancer Res 79(7):1285\u20131292. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2965","journal-title":"Cancer Res"},{"issue":"1","key":"10108_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12935-025-03736-8","volume":"25","author":"X Pu","year":"2025","unstructured":"Pu X, Wu Y, Long W, Sun X, Yuan X, Wang D et al (2025) The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis. Cancer Cell Int 25(1):122. https:\/\/doi.org\/10.1186\/s12935-025-03736-8","journal-title":"Cancer Cell Int"},{"issue":"20","key":"10108_CR40","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1080\/15384101.2023.2283328","volume":"22","author":"T Wu","year":"2023","unstructured":"Wu T, Liao L, Wu T, Chen S, Yi Q, Xu M (2023) IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification. Cell Cycle 22(20):2245\u20132263. https:\/\/doi.org\/10.1080\/15384101.2023.2283328","journal-title":"Cell Cycle"}],"updated-by":[{"DOI":"10.1007\/s10863-026-10113-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000}}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10108-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:36:45Z","timestamp":1780018605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10108"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10108-y","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10863-026-10113-1","URL":"https:\/\/doi.org\/10.1007\/s10863-026-10113-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was formally approved by the ethics committee of Xi\u2019an Central Hospital. All experiments on human subjects were conducted in accordance with the Declaration of Helsinki and that all procedures were carried out with the adequate understanding and written consent of the subjects. All animal experiments complied with ARRIVE guidelines, and were carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}